Navigation Links
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
Date:10/22/2008

h expense associated with writing-off the

acquired in-process research and development ("IPR&D") related to the

acquisitions of Alantos and Ilypsa in 2007.

(k) To exclude the impairment of a non-ENBREL related intangible asset

previously acquired in the Immunex acquisition.

(l) To exclude the impact of writing-off the cost of a semi-completed

manufacturing asset that will not be used due to a change in

manufacturing strategy.

(m) To exclude merger related expenses incurred due to the Abgenix

acquisition, primarily related to incremental costs associated with

recording inventory acquired at fair value which is in excess of our

manufacturing cost.

(n) To exclude the pro rata portion of the deferred financing and related

costs that were immediately charged to interest expense as a result of

certain holders of our convertible notes due in 2032 exercising their

March 1, 2007 put option and the related convertible notes being

repaid in cash.

(o) To reflect the tax effect of the above adjustments for 2008, excluding

(1) certain components of the write-off of inventory (see (b) above),

(2) certain of the restructuring charges (see (e) above), (3) certain

of the loss accruals for settlements of commercial legal proceedings

(see (f) above) and (4) certain components of the loss accrual on the

sale of certain less significant marketed products and related assets

(see (g) above).

(p) To exclude the income tax benefit recognized as the result of

resolving certain non-routine transfer pricing issues with the

Internal Revenue Service ("IRS") for prior periods.

(q) To reflect the tax effect of the above adjustments for 2007, excluding

(1) certain of the restructuring charges (see(e) above), (2) certain

components of t
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. CNS Response Announces Fiscal Third Quarter 2007 Results
2. Avitar Reports Third Quarter Financial Results for Fiscal 2007
3. Martek to Announce Third Quarter 2007 Results on September 5, 2007
4. Third Security, LLC Hires Two New Managing Directors
5. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
6. ThirdBiotech Networking Group Launches
7. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
8. PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call
9. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
10. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Continuing its long ... infarction (MI), Beckman Coulter , Inc. announces the ... its new Access AccuTnI+3 troponin I assay for use ... "Clinicians have depended on Beckman Coulter,s troponin ... AccuTnI+3 assay has the proven performance to continue providing ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Bayer CropScience ... first Bayer Bee Care Community Leadership Award. The award ... Congressional Reception in Washington, D.C., an event where ... to the world’s food supply. , The Bayer ... harnessed the power of the honey bee colony to ...
(Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... with financial software provider BlackLine Systems  and enterprise ... SAP ) for a webinar next week entitled "No ... from BlackLine and SAP to Help Keep Its Account Reconciliations ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at finance, ...
(Date:6/19/2013)... Bloomington, Indiana (PRWEB) June 19, 2013 ... Valentine joined the speaking faculty at 2013’s BioLogistics ... , The conference, coordinated by Cold Chain IQ ... surrounding biologics. This “complexity” is, in part, attributed ... medicine. , “Implicit within these trends is ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2
... Former AstraZeneca Exec to Lead Hong Kong-based subsidiary Pangu ... held biopharmaceutical company focused on discovery and development of ... for multiple disease indications, today announced that Dr. James ... of Clinical Development at aTyr Pharma and President of ...
... One Corporation (Pink Sheets: MNCN), announced today that its ... serve as the company,s Chief Financial Officer, effective March ... said, "Pat brings a strong background in finance to ... financial expertise will be great assets to Mach One ...
... Alternext US: CVM) announced today that it is ... allow drugs developed using stem cells and other biological ... their shelf life. The availability of this new ... time to market by eliminating complicated and time consuming ...
Cached Biology Technology:Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 2Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 3Mach One Announces Appointment of Chief Financial Officer 2CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 2CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 3CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 4
(Date:6/19/2013)... for human consumption qualifies as a gluten-free cereal that ... scientists have confirmed in a study published in ACS, ... , Joyce Irene Boye and colleagues point out that ... alone have CD. They develop gastrointestinal and other symptoms ... contain gluten-related proteins. Boye,s team sought to expand dietary ...
(Date:6/19/2013)... fall 2012, the European Medicines Agency (EMA) approved ... first ever gene therapy for clinical use in ... had developed AAV-LPL S447X for the treatment of ... deficiency (LPLD) which affects approximately one or two ... severe, life-threatening inflammations of the pancreas. Afflicted individuals ...
(Date:6/18/2013)... Arlington environmental engineer has been awarded a $394,300 ... ensure water quality and flow in the new ... Andrew Kruzic, UT Arlington associate professor of civil ... to add monochloramine to the water in an ... pump stations and pipelines. Adding monochloramine is widely ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... its eruption in early June, several NASA satellites have captured ... Chilean Volcano called Puyehue-Cordn Caulle and have tracked it around ... FLICKR image gallery that shows the progression of the plume ... Complex includes the Puyehue volcano, the Cordn Caulle rift zone ...
... June 15, 2011 A first of its kind ... Energy,s Oak Ridge National Laboratory is providing a close-up ... Lignin, a major component of plant cell walls, aggregates ... of cellulosic ethanol. The exact shape and structure of ...
... that add up over time could create an evolutionary express ... researchers from the University of Pittsburgh and the University of ... the Proceedings of the National Academy of Sciences ... known as transcriptional enhancerswhich determine the when, where, and how ...
Cached Biology News:NASA satellite gallery shows Chilean volcano plume moving around the world 2NASA satellite gallery shows Chilean volcano plume moving around the world 3ORNL neutrons, simulations reveal details of bioenergy barrier 2Leaky genes put evolution on the fast track, Pitt and UW-Madison researchers find 2
Spastin (Sp 3G11/1)...
... MaV203 Competent Yeast Cells are designed for ... 1). S. cerevisiae strain MaV203 contains deletions ... for use with GAL4-based two-hybrid systems. The ... for selection of ProQuest bait and prey ...
...
Recombinant Rhesus Macaque IFN-alpha...
Biology Products: